Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database
- PMID: 33169397
- DOI: 10.1002/jso.26292
Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database
Abstract
Background and objectives: Adenocarcinoma patterns could be grouped based on clinical behaviors: low- (lepidic), intermediate- (papillary or acinar), and high-grade (micropapillary and solid). We analyzed the impact of the second predominant pattern (SPP) on disease-free survival (DFS).
Methods: We retrospectively collected data of surgically resected stage I and II adenocarcinoma.
Selection criteria: anatomical resection with lymphadenectomy and pathological N0. Pure adenocarcinomas and mucinous subtypes were excluded. Recurrence rate and factors affecting DFS were analyzed according to the SPP focusing on intermediate-grade predominant pattern adenocarcinomas.
Results: Among 270 patients, 55% were male. The mean age was 68.3 years. SPP pattern appeared as follows: lepidic 43.0%, papillary 23.0%, solid 14.4%, acinar 11.9%, and micropapillary 7.8%. The recurrence rate was 21.5% and 5-year DFS was 71.1%. No difference in DFS was found according to SPP (p = .522). In patients with high-grade SPP, the percentage of SPP, age, and tumor size significantly influenced DFS (p = .016). In patients with lepidic SPP, size, male gender, and lymph-node sampling (p = .005; p = .014; p = .038, respectively) significantly influenced DFS.
Conclusions: The impact of SPP on DFS is not homogeneous in a subset of patients with the intermediate-grade predominant patterns. The influence of high-grade SPP on DFS is related to its proportion in the tumor.
Keywords: lung adenocarcinoma; lung cancer biology; lung cancer surgery; non-small-cell lung cancer.
© 2020 Wiley Periodicals LLC.
References
REFERENCES
-
- Zhang R, Chen C, Dong X, et al. Independent validation of early-stage NSCLC prognostic scores incorporating epigenetic and transcriptional biomarkers with gene-gene interactions and main effects. Chest. 2020;158:808-819. https://doi.org/10.1016/j.chest.2020.01.048
-
- Travis WD, Brambilla E, Noguchi M, et al. International Association for the study of lung cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of lung adenocarcinoma. J Thorac Oncol. 2011;6(2):244-285. https://doi.org/10.1097/JTO.0b013e318206a22
-
- Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization Classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 Classification. J Thorac Oncol. 2015;10(9):1243-1260. https://doi.org/10.1097/JTO.0000000000000630
-
- Sica G, Yoshizawa A, Sima CS, et al. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol. 2010;34(8):1155-1162. https://doi.org/10.1097/PAS.0b013e3181e4ee32
-
- Warth A, Muley T, Meister M, et al. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol. 2012;30(13):1438-1446. https://doi.org/10.1200/JCO.2011.37.2185
MeSH terms
LinkOut - more resources
Miscellaneous